Editas: 4Q Earnings Snapshot

·1 min read

CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Thursday reported a loss of $62.5 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1 per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.

The genome editing company posted revenue of $11.4 million in the period, which beat Street forecasts. Four analysts surveyed by Zacks expected $6.8 million.

For the year, the company reported that its loss narrowed to $116 million, or $1.98 per share. Revenue was reported as $90.7 million.

Editas shares have dropped 30% since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT